Intracellular delivery of oxaliplatin conjugate via cell penetrating peptide for the treatment of colorectal carcinoma in vitro and in vivo
- Abstract
- Pt-based drugs are one of the main active agents in colorectal cancer treatment. However, drug resistance and dose-dependent side effects are the main barriers that restrict their clinical applications. As an alternative approach to these issues, we designed and synthesized a cell penetrating peptide (CPP) octaarginine-oxaliplatin conjugate that quickly and successfully delivered oxaliplatin into colon cancer cells. The CPP octaarginine is a well-studied cationic peptide that can play a role as a drug delivery vector. In this work, an octaarginine CPP (RRRRRRRR) was conjugated with oxaliplatin via a specific heterobifunctional linker. The in vitro studies showed the conjugate had affinity toward mitochondria inside cells and the MTT assay confirmed that conjugate is active in low micromolar range against colon cancer cells, requiring much lower concentrations than the oxaliplatin alone to reach IC(50). More importantly, in the in vivo mouse study, the conjugate effectively inhibited tumor growth and showed considerably high antitumor activity, demonstrating the conjugate can perform well in vivo. This strategy may offer a new approach for designing oxaliplatin derivatives or prodrugs with remarkable therapeutic capabilities.
- All Author(s)
- T. Singh
; D. H. Kang
; T. W. Ki
; H. J. Kong
; J. S. Ryu
; S. Jeon
; T. S. Ahn
; D. Jeong
; M. J. Baek
; J. Im
- Issued Date
- 2021
- Type
- Article
- Keyword
- Animals; *Antineoplastic Agents/therapeutic use; Cell Line, Tumor; *Cell-Penetrating Peptides/therapeutic use; *Colorectal Neoplasms/drug therapy; Drug Delivery Systems; Mice; Oxaliplatin; Bioconjugate; Cell penetrating peptide; Colorectal cancer; Drug delivery
- ISSN
- 0378-5173
; 1873-3476
- Citation Title
- International journal of pharmaceutics
- Citation Volume
- 606
- Citation Start Page
- 120904
- Citation End Page
- 120904
- Language(ISO)
- eng
- DOI
- 10.1016/j.ijpharm.2021.120904
- URI
- http://schca-ir.schmc.ac.kr//handle/2022.oak/317
- 공개 및 라이선스
-
- 파일 목록
-
Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.